Multivalent-Based Drug Design Applied to Serotonin 5-HT4 Receptor Oligomers

E-ISSN： 1873-4286|15|6|719-729

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.6, 2009-02, pp. : 719-729

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serotonin Type-4 (5-HT4) Receptors as Therapeutic Targets: 5-HT4 Receptor Antagonists

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 3, Iss. 1, 2003-03 ,pp. : 37-42

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacophores of 5-HT4 Receptor Ligands: Experience of CERMN and Implications for Drug Design

Current Computer - Aided Drug Design, Vol. 4, Iss. 3, 2008-09 ,pp. : 199-208

Bentham Science Publishers

Access to resources Recommend Favorite

Serotonin Type-4 (5-HT4) Receptors as Therapeutic Targets: Past and Future Roles of 5-HT4 Receptor Agonists

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 3, Iss. 1, 2003-03 ,pp. : 27-36

Bentham Science Publishers

Access to resources Recommend Favorite

Serotonin 5-HT7 Receptor Antagonists

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 4, Iss. 3, 2004-09 ,pp. : 203-214

Bentham Science Publishers

Access to resources Recommend Favorite

Involvement of the 5-HT 2 receptor in hyperthermia induced by p-chloroamphetamine, a serotonin-releasing drug in mice

By Sugimoto Y. Ohkura M. Inoue K. Yamada J.

European Journal of Pharmacology, Vol. 403, Iss. 3, 2000-09 ,pp. : 225-228

Elsevier

Access to resources Recommend Favorite